Evidence map›Paper›PMID 33456999›Full record

ArticleJournal of gastrointestinal oncology2020

Short and long-term outcomes after proximal gastrectomy with double tract reconstruction for Siewert type III adenocarcinoma of the esophagogastric junction: a propensity score matching study from a 10-year experience in a high-volume hospital.

Fei Ma, Dandan Guo, Bin Zhang, Yonglei Zhang, Liangqun Peng, Qi Ma, Sheqing Ji, Junhui Chai, Yawei Hua, Xiaobing Chen and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Fei MaDepartment of General Surgery, the Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.
Dandan GuoDepartment of Radiology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Bin ZhangDepartment of General Surgery, the Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.
Yonglei ZhangDepartment of General Surgery, the Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.
Liangqun PengDepartment of General Surgery, the Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.
Qi MaDepartment of General Surgery, the Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.
Sheqing JiDepartment of General Surgery, the Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.
Junhui ChaiDepartment of General Surgery, the Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.
Yawei HuaDepartment of General Surgery, the Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.
Xiaobing ChenDepartment of Medical Oncology, the Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.
Hui WangDepartment of Medical Oncology, the Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.
Shuning XuDepartment of Medical Oncology, the Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.
Suxia LuoDepartment of Medical Oncology, the Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.
Zhengzhou University · CNThird Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTotal gastrectomy and proximal gastrectomy (PG) are both surgical options for the treatment of Siewert type III adenocarcinoma of the esophagogastric junction (AEG). Currently there is no consensus on selecting which procedure to perform; in particular, there are few reports of long-term outcomes for patients with local advanced AEG. The aim of this study was to validate the usefulness of PG with double-tract reconstruction in Siewert type III AEG.

methodsThe clinical data of patients with Siewert type III AEG underwent PG with double-tract reconstruction (PG-DT) or total gastrectomy with Roux-en-Y anastomosis (TG-RY) at our hospital between October 2010 and October 2018. According to the defined inclusion and exclusion criteria, 2,146 cases were enrolled in this study. A 1-to-1 propensity score matching (PSM) was performed to compare the short and long-term outcomes between the 2 groups.

resultsThe operation time was longer in the PG-DT group, and the proportion rates of complications and recovery time was similar in the 2 groups. The rates of maintaining bodyweight and free-fat mass index were significantly higher in patients who underwent PG-DT compared to those who underwent TG-RY. While complications, recovery time and survival are similar between two groups.

conclusionsRegarding short-term outcomes, PG-DT seemed to be superior in terms of maintaining body weight and skeletal muscle compared to TG-RY, while both had similar complications. It was found that PG-DT enabled a potentially longer survival of pathological stage II and III Siewert type III AEG, although the finding was statistically insignificant. These results may help surgeons to determine the appropriate surgical approach and strategy for patients with early and locally advanced Siewert type III AEG.

Indexed as

Adenocarcinoma of the esophagogastric junction (AEG)digestive tract reconstructiondouble-tract reconstructionproximal gastrectomy (PG)

Identifiers

PMID33456999
PMCPMC7807272
OpenAlexW3117745413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.